Improving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway
暂无分享,去创建一个
A. Martelli | A. Pession | F. Locatelli | L. Neri | F. Buontempo | C. Evangelisti | A. Cappellini | L. Zambonin | A. Lonetti | F. Chiarini | A. Bertaina | E. Orsini | C. Evangelisti